What does cabergoline do?

Cabergoline, an ergot derivative with significant pharmacological activity, has occupied a place in the medical field with its unique mechanism of action.

Cabergoline primarily functions as a dopamine receptor agonist. It can bind to dopamineD2 receptors powerfully, long-actingly and highly selectively, thereby producing a series of pharmacological effects. This property gives cabergoline significant advantages in the treatment of certain diseases.

Cabergoline is an effective drug in the treatment of hyperprolactinemia. After administration of cabergoline, prolactin can be suppressed for two weeks due to stimulation of dopamine receptors, significantly reducing the patient's blood prolactin level. This effect is important in alleviating symptoms caused by hyperprolactinemia.

Cabergoline is also trialled for the treatment of Parkinson's disease. Parkinson's disease is a chronic progressive neurological disease. The dopamine receptor agonistic effect of cabergoline helps improve patients' motor functions and daily living abilities. However, the evidence for the use of cabergoline in the treatment of Parkinson's disease is insufficient, so the drug must be used with caution and the treatment plan adjusted according to the patient's specific conditions.

In addition to the main applications mentioned above, cabergoline has also been tried in the treatment of diseases such as breast cancer. These potential applications demonstrate the broad promise of cabergoline in the medical field, but more clinical evidence is needed to support its effectiveness.

Although cabergoline is excellent in the treatment of certain conditions, its use comes with caveats and possible side effects. For example, cabergoline should be contraindicated in people who are allergic to ergot preparations, pregnant women, breastfeeding people, and those with a history of severe mental illness. In addition, possible adverse reactions of long-term medication include nausea, vomiting, dizziness, hypotension, etc. Therefore, patients should be closely observed during use and seek medical treatment in time.